Evidence map›Paper›PMID 39202418›Full record

ArticleGenes2024

Optimization of Phycocyanobilin Synthesis in

Julia Esclapez, Laura Matarredona, Guillermo Zafrilla, Mónica Camacho, María-José Bonete, Basilio Zafrilla

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julia EsclapezDepartment of Biochemistry and Molecular Biology and Soil Science and Agricultural Chemistry, Faculty of Science, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain.ORCID 0000-0003-4409-4400
Laura MatarredonaDepartment of Biochemistry and Molecular Biology and Soil Science and Agricultural Chemistry, Faculty of Science, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain.
Guillermo ZafrillaDepartment of Biochemistry and Molecular Biology and Soil Science and Agricultural Chemistry, Faculty of Science, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain.
Mónica CamachoDepartment of Biochemistry and Molecular Biology and Soil Science and Agricultural Chemistry, Faculty of Science, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain.ORCID 0000-0002-5843-216X
María-José BoneteDepartment of Biochemistry and Molecular Biology and Soil Science and Agricultural Chemistry, Faculty of Science, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain.ORCID 0000-0003-0714-3998
Basilio ZafrillaDepartment of Biochemistry and Molecular Biology and Soil Science and Agricultural Chemistry, Faculty of Science, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain.ORCID 0000-0001-5582-4355

Funding

Generalitat Valenciana GV/2020/215Vicerrectorado de Investigación. Universidad de Alicante VIGROB-016
6 · The paper itself

Abstract

Phycocyanobilin (PCB) is a small chromophore found in certain phycobiliproteins, such as phycocyanins (PCs) and allophycocyanins (APCs). PCB, along with other phycobilins (PBs) and intermediates such as biliverdin (BV) or phycoerythrobilin (PEB), is attracting increasing biotechnological interest due to its fluorescent and medicinal properties that allow potential applications in biomedicine and the food industry. This study aims to optimize PCB synthesis in

Indexed as

BioreactorsEscherichia coliPhycobilinsPhycocyaninBiotechnologyPhycobilinsPhycocyaninphycocyanobilinbioreactorbiosynthesisBL21 (DE3)heterologous expressionHO1optimizationPCYAphycocyanobilin

Identifiers

PMID39202418
PMCPMC11353606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.